The Novo Holdings Executive Leadership Team is comprised of six members. The Novo Holdings Board of Directors is comprised of nine members, representing the life science and asset management industries.

The Novo Advisory Group is an expert panel that supports Novo Holdings in analysing and monitoring its larger life science investments.